Universe Pharmaceuticals Inc.
NasdaqCM:UPC
Sector
Location
Market Cap
USD 1.96 M
Share Price
USD 3.48
Avg Daily Volume
61,314
Change (1 day)
1.51%
Change (1 year)
-99.83%
Change (YTD)
-85.73%
Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2024: USD -7.36 M
Universe Pharmaceuticals Inc. EBITDA is USD -7.36 M for the year ending September 30, 2024, a 128.82% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2023 was USD -3.22 M, a -49.75% change year over year.
-
Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2022 was USD -6.40 M, a -145.07% change year over year.
-
Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2021 was USD 14.20 M, a 33.77% change year over year.
-
Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2020 was USD 10.61 M, a 4.31% change year over year.
StockViz
Competitors
McKesson Corporation
USD 689.45
MCK
-16.55
-2.34%
Cencora, Inc.
USD 292.60
COR
-10.63
-3.51%
Cardinal Health, Inc.
USD 148.10
CAH
-3.47
-2.29%
JD Health International Inc.
USD 8.13
6618.HK
-0.12
-1.44%
Sigma Healthcare Limited
USD 1.85
SIG.AX
+0.02
1.09%
Yunnan Baiyao Group Co.,Ltd
USD 8.04
000538.SZ
+0.04
0.47%
Alibaba Health Information Technology Limited
USD 0.71
0241.HK
+0.00
0.03%
Walgreens Boots Alliance, Inc.
USD 12.07
WBA
-0.12
-0.98%
Bangkok Dusit Medical Services Public Company Limited
USD 0.65
BDMS.BK
+0.00
0.24%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.00
-0.05%
MatsukiyoCocokara & Co.
USD 21.10
3088.T
-0.07
-0.35%
Sinopharm Group Co. Ltd.
USD 2.50
1099.HK
-0.02
-0.73%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
USD 4.29
000999.SZ
+0.01
0.26%
Beijing Tongrentang Co., Ltd
USD 5.18
600085.SS
-0.00
-0.02%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.38
0874.HK
-0.02
-0.77%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
McKesson Corporation
USD 689.45
MCK
-16.55
-2.34%
Cencora, Inc.
USD 292.60
COR
-10.63
-3.51%
Cardinal Health, Inc.
USD 148.10
CAH
-3.47
-2.29%
JD Health International Inc.
USD 8.13
6618.HK
-0.12
-1.44%
Sigma Healthcare Limited
USD 1.85
SIG.AX
+0.02
1.09%
Yunnan Baiyao Group Co.,Ltd
USD 8.04
000538.SZ
+0.04
0.47%
Alibaba Health Information Technology Limited
USD 0.71
0241.HK
+0.00
0.03%
Walgreens Boots Alliance, Inc.
USD 12.07
WBA
-0.12
-0.98%
Bangkok Dusit Medical Services Public Company Limited
USD 0.65
BDMS.BK
+0.00
0.24%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.00
-0.05%
MatsukiyoCocokara & Co.
USD 21.10
3088.T
-0.07
-0.35%
Sinopharm Group Co. Ltd.
USD 2.50
1099.HK
-0.02
-0.73%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
USD 4.29
000999.SZ
+0.01
0.26%
Beijing Tongrentang Co., Ltd
USD 5.18
600085.SS
-0.00
-0.02%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.38
0874.HK
-0.02
-0.77%